Sol Bamba: Former Hibs and Dunfermline centre-back diagnosed with Non-Hodgkin lymphoma

Sol Bamba, former Hibs and Dunfermline star, has been diagnosed with a rare form of cancer.

The 35-year-old centre back was revealed to suffer from Non-Hodgkin lymphoma, which affects the body’s lymphatic system.

In a statement on Monday, Mr Bamba’s current club, Cardiff City said: "We are saddened to inform supporters that Sol Bamba has been diagnosed with Non-Hodgkin lymphoma.⁣

"With the close support of the Club's medical team, Sol has immediately started a course of chemotherapy treatment.⁣

Sol Bamba, former Hibs and Dunfermline star, has been diagnosed with a rare form of cancer. (Photo by Wattie Cheung/Getty Images)

"Universally admired by teammates, staff and supporters in the Welsh capital, Sol has begun his battle in typically positive spirits and will continue to be an integral part of the Bluebirds family.

"During treatment, Sol will support his teammates at matches and our younger players within the Academy, with whom he will continue his coaching development.⁣

"All future updates on Sol’s progress will be provided only via official Club channels.

“Messages of support to be passed on to Sol may be sent to [email protected].⁣

"We are all with you, Sol."

SkySports’ Geoff Shreeves wrote: "That is awful news. Wishing Sol a full recovery as soon as possible."

Former Cardiff player Andy Legg wrote: "Sol I’m so shocked to hear this news and I am saddened by it.

"But I know how strong you are as a person and I know you will get through this battle.”

After an initial trial period, Bamba signed for Dunfermline Athletic in July 2006, helping the club to reach the 2007 Scottish Cup Final.

The Nigerian international moved to Hibs on a three-year contract.

A message from the Editor:

Thank you for reading this article. We're more reliant on your support than ever as the shift in consumer habits brought about by coronavirus impacts our advertisers.

If you haven't already, please consider supporting our trusted, fact-checked journalism by taking out a digital subscription.